Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
Recruiting · NCT02664831 · Observational (researchers observe without assigning treatment) · Lead sponsor: MaineHealth
View the official record on ClinicalTrials.gov →What this trial is about
This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.
Who can take part
Inclusion criteria
- Aged 18 years or older
- Admitted to the intensive care unit after cardiac arrest episode
- Unresponsive after resuscitation
Exclusion criteria
- Moribund / actively dying at the time of evaluation
- Informed consent cannot be obtained within 24 hours of resuscitation
- Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion
Where it is running
1 location listed across 1 US state.
- Maine Medical Center - Portland, Maine, United States